Idebenone and T2D: A new insulin-sensitizing drug for personalized therapy
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference11 articles.
1. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes;DeFronzo;Diabetes Care,2009
2. Insulin receptor signaling in normal and insulin-resistant states;Boucher;Cold Spring Harb. Perspect. Biol.,2014
3. p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans;Ciciliot;Diabetologia,2015
4. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain;Gustafson;Mol. Cell Biol.,1995
5. Therapeutic advances and future prospects in progressive forms of multiple sclerosis;Shirani;Neurotherapeutics,2016
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Metformin: From diabetes to cancer to prolongation of life;Pharmacological Research;2024-10
2. GLP-1R mediates idebenone-reduced blood glucose in mice;Biomedicine & Pharmacotherapy;2024-09
3. Coenzyme Q-related compounds to maintain healthy mitochondria during aging;Advances in Protein Chemistry and Structural Biology;2023
4. Mitochondria-targeted antioxidants: coenzyme Q10, mito-Q and beyond;Molecular Nutrition and Mitochondria;2023
5. The Insulin Receptor: An Important Target for the Development of Novel Medicines and Pesticides;International Journal of Molecular Sciences;2022-07-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3